treatment-resistant depression

FDA Approves Esketamine Nasal Spray for Treatment-Resistant Depression

The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This ...

Hosted on MSN34m

FDA Clears Spravato For Monotherapy Depression Treatments

The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...

40mon MSN

New Nasal Spray to Treat Depression Gets FDA Approval

The U.S. Food and Drug Administration has approved a nasal spray to treat depression—the first-ever stand-alone medication for patients with severe depression. Johnson & Johnson said patients who use ...

FDA approves first nasal spray treatment for severe depression

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...

Using machine learning to predict how people diagnosed with major depressive disorder respond to treatment

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

mic3h

A Nasal Spray For Depression? FDA Gives Its Approval

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...

FOX 10 Phoenix4h

FDA approves first-of-its-kind nasal spray to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression. Here's what ...

Nose spray to treat depression? FDA approves first-of-its-kind medicine

The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

FDA Approves Nasal Spray for Depression

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...